Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Publications & Presentations

    56. Skrepnek G H, Sahai A, Antoine R. An Improved Minimum Mean Squared Error Estimate of the Square of the Normal Population Variance Using Computational Intelligence. Journal of Applied Mathematics and Bioinformatics. 2015; 5 : 53-65

    57. Skrepnek G H, Thompson T C, Johnson E J. Debt and Taxes: Marginal Tax Rate Changes, Capital Structure, and Innovative Activity in the Biotechnology Sector. Journal of Commercial Biotechnology. 2015; 21 : 19-30

    58. Skrepnek G H, Tate W R, Baker A F. Clinical and Economic Burden of Richter Syndrome in Inpatient Cases of Chronic Lymphocytic Leukemia within the United States, 2001-2010. Leukemia and Lymphoma. 2014; 55 : 834-840

    59. Olvey E L, Guy M C, Chang J, Skrepnek G H. Cost-Effectiveness of Medication Therapy Management in Medicare Part-D Diabetic Enrollees. American Journal of Pharmaceutical Benefits. 2014; 6 : 147-156

    60. Gilligan A, Skrepnek G H. Determinants of Life Expectancy in the Eastern Mediterranean Region. Health Policy and Planning. 2014




Grants

<< 1 2 3 4 >>
    11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.

    12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.

    13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.

    14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.

    15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.

<< 1 2 3 4 >>



Awards and Honors


no results

Education


no results

Administrative Assignments

                                                

    1. Role: Director. Scope: Department. Date: 2019.

                                                

    2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.